Table 2.
Pre-treatment Characteristics, CD34 measured by AQUA®
| Missing CD34 (n=44) | Determined CD34 (n=34) | CD34 < Median (n=17) | CD34 ≥ Median (n=17) | |
|---|---|---|---|---|
| Age | ||||
| Median | 44 | 47 | 48 | 45 |
| Range | 24 – 68 | 30 – 66 | 30 – 66 | 31 – 59 |
| n | % | n | % | n | % | n | % | |
|---|---|---|---|---|---|---|---|---|
| Zubrod | ||||||||
| 0 | 37 | 84 | 20 | 59 | 10 | 59 | 10 | 59 |
| 1 | 6 | 14 | 13 | 38 | 7 | 41 | 6 | 35 |
| 2 | 1 | 2 | 1 | 3 | 0 | 0 | 1 | 6 |
| FIGO Stage | ||||||||
| IB | 8 | 18 | 10 | 29 | 6 | 35 | 4 | 24 |
| IIA | 1 | 2 | 3 | 9 | 3 | 18 | 0 | 0 |
| IIB | 24 | 55 | 16 | 47 | 7 | 41 | 9 | 53 |
| IIIB | 9 | 20 | 4 | 12 | 1 | 6 | 3 | 18 |
| IVA | 2 | 5 | 1 | 3 | 0 | 0 | 1 | 6 |
| Pelvic Lymph Nodes | ||||||||
| Not Evaluable | 2 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Negative | 35 | 80 | 29 | 85 | 14 | 82 | 15 | 88 |
| Positive | 7 | 16 | 3 | 9 | 2 | 12 | 1 | 6 |
| Equivocal | 0 | 0 | 2 | 6 | 1 | 6 | 1 | 6 |
| Histology | ||||||||
| Squamous cell carcinoma | 39 | 89 | 29 | 85 | 15 | 88 | 14 | 82 |
| Adenocarcinoma | 3 | 7 | 5 | 15 | 2 | 12 | 3 | 18 |
| Adenosquamous | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hydronephrosis | ||||||||
| None | 41 | 93 | 30 | 88 | 17 | 100 | 13 | 76 |
| Unilateral | 3 | 7 | 3 | 9 | 0 | 0 | 3 | 18 |
| Bilateral | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 6 |